| Stuart Feldman, MD | |
|
1601 Clint Moore Rd, Boca Raton, FL 33487-2768 | |
| (908) 653-9399 | |
| Not Available |
| Full Name | Stuart Feldman |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 34 Years |
| Location | 1601 Clint Moore Rd, Boca Raton, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669571543 | NPI | - | NPPES |
| 268381400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME68861 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lucie Anesthesia Associates Llc | 4284792706 | 106 |
News Archive
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
Researchers at the University of Rochester Medical Center have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of a wide range of diseases, including Alzheimer's, Parkinson's, ALS, and brain cancer.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S., have shown that an immunotherapy that until now has only been available to patients enrolled in research studies, is equivalent to the product that has been manufactured for commercial use and can be made available to all patients.
› Verified 1 days ago
| Entity Name | Spine Institute Of South Florida Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700970126 PECOS PAC ID: 3870565963 Enrollment ID: O20040810000182 |
News Archive
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
Researchers at the University of Rochester Medical Center have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of a wide range of diseases, including Alzheimer's, Parkinson's, ALS, and brain cancer.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S., have shown that an immunotherapy that until now has only been available to patients enrolled in research studies, is equivalent to the product that has been manufactured for commercial use and can be made available to all patients.
› Verified 1 days ago
| Entity Name | St Lucie Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700044252 PECOS PAC ID: 4284792706 Enrollment ID: O20081027000765 |
News Archive
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
Researchers at the University of Rochester Medical Center have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of a wide range of diseases, including Alzheimer's, Parkinson's, ALS, and brain cancer.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S., have shown that an immunotherapy that until now has only been available to patients enrolled in research studies, is equivalent to the product that has been manufactured for commercial use and can be made available to all patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stuart Feldman, MD Po Box 850001 Dept 991, Orlando, FL 32886-0991 Ph: (800) 248-1639 | Stuart Feldman, MD 1601 Clint Moore Rd, Boca Raton, FL 33487-2768 Ph: (908) 653-9399 |
News Archive
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
Researchers at the University of Rochester Medical Center have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of a wide range of diseases, including Alzheimer's, Parkinson's, ALS, and brain cancer.
During a House Committee on Foreign Affairs' hearing on the future of PEPFAR Wednesday, U.S. Global AIDS Coordinator Ambassador Eric Goosby assured lawmakers that the decision by President Barack Obama to make PEPFAR part of the president's Global Health Initiative (GHI) would not compromise "the widely praised plan," CQ HealthBeat reports.
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S., have shown that an immunotherapy that until now has only been available to patients enrolled in research studies, is equivalent to the product that has been manufactured for commercial use and can be made available to all patients.
› Verified 1 days ago
Anthony Riso, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 771 Ne 33rd St, Boca Raton, FL 33431 Phone: 561-247-1020 Fax: 954-510-2060 | |
Dr. Juan P Giraldo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 660 Glades Rd, Suite 460, Boca Raton, FL 33431 Phone: 561-391-5515 Fax: 561-347-7470 | |
Dr. Erik A Cooper, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7926 Tennyson Ct, Boca Raton, FL 33433 Phone: 412-728-4256 | |
Dr. Kenneth Lawrence Ross, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 785 Ne 33rd St, Boca Raton, FL 33431 Phone: 561-750-1130 Fax: 561-750-1130 | |
George R Luck, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-395-7100 | |
Azra Khan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7100 W Camino Real, Suite 301, Boca Raton, FL 33433 Phone: 772-924-2527 | |
Dr. David Lee Dresner, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22503 Esplanada Cir W, Boca Raton, FL 33433 Phone: 561-562-7755 |